S. Douglas Sheldon

Mr. Sheldon is an accomplished entrepreneur and pharmaceutical executive with over 30 years of global experience. He currently serves as the Executive Chairman of the Board of Directors at Indochina Healthcare Ltd., a Bangkok-based, regionally focused specialty Pharma and medical device company which he founded in 1994. Mr. Sheldon co-founded EKR Therapeutics, a specialty pharmaceutical company focused on the hospital critical care market, ESP Pharma, a start-up which was successfully commercialized and later acquired by PDL BioPharma, and ESP Equity Partners, where he is the Managing Partner.

His previous experience includes senior level executive positions at Warner Lambert, Parke Davis and Pfizer. During his 17-year career at Pfizer, Mr. Sheldon held positions of Country Manager/CEO and Regional Vice President for Asia.

Mr. Sheldon earned MBA degree from Syracuse University and BS in Chemistry from LeMoyne College. He served as a Lt. Commander in the US Navy and is bilingual in English/Spanish.

Management Team